Sebastian Rühl

Sebastian Rühl, PhD, currently serves as a Senior Researcher at T3 Pharmaceuticals AG since October 2022. Prior to this role, Sebastian worked as a postdoctoral researcher at St. Jude Children's Research Hospital from June 2018 to September 2022, focusing on the mechanisms of apoptosis induction in cancer and the regulation of chemoresistance by novel Bcl-2 proteins. Sebastian's academic journey includes a PhD at the University of Basel from March 2014 to March 2018, where supervision, lab work, data analysis, literature research, and publication writing were key responsibilities. Earlier educational achievements include a Master of Science in Biochemistry obtained in 2013 and a Bachelor of Science in Molecular Biology awarded in 2013, both from the University of Basel.